Data / Form D filings / Mach5 Therapeutics, Inc.
Mach5 Therapeutics, Inc.: Form D filings
Mach5 Therapeutics, Inc., a biotechnology company in Atlanta, GA, filed 3 Form D notices with the SEC in 2024. The latest, on November 4, 2024, reports $19.2 million sold of a $19.9 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 650 PONCE DE LEON AVE, STE. 300 #2347, Atlanta, GA, 30308
- Phone
- (404) 487-8769
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2018014
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2024 | New notice | $19,929,508 | $19,179,509 | $749,999 | 15 | Oct 24, 2024 | sec.gov |
| Apr 17, 2024 | Amendment | $4,500,000 | $4,175,000 | $325,000 | 7 | Mar 21, 2024 | sec.gov |
| Apr 3, 2024 | New notice | $2,999,998 | $2,674,996 | $325,002 | 6 | Mar 21, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick J. Crutcher | Executive Officer, Director | |
| Justin J. DiMartino | Executive Officer, Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Nov 4, 2024 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mach5 Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.